Humanized anti-CD20 monoclonal antibody

Details for Australian Patent Application No. 2006339830 (hide)

International Classifications

Event Publications

25 September 2008 PCT application entered the National Phase

PCT publication WO2007/102230 Priority application(s): WO2007/102230

7 April 2011 Application Accepted

Published as AU-B-2006339830

4 August 2011 Standard Patent Sealed

8 December 2011 Offer to Surrender

Osaka University 1-1, Yamadaoka , Suita-shi Osaka 5650871, the Patentee of Letters Patent 2006339830 dated 21.07.2011 for an invention titled ' Humanized anti-CD20 monoclonal antibody' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal. Offer to Surrender

2 February 2012 Offer to Surrender

The offer by the Patentee Osaka University to surrender Letters Patent 2006339830 which was advertised in the Official Journal of 08.12.2011 has been accepted and the Letters Patent has been revoked in accordance with Section 137 of the Patents Act.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.